The Europe Vascular Access Device Market should witness market growth of 7.0% CAGR during the forecast period (2023-2030).
Intestinal atresia, small bowel syndrome, and different kinds of cancer are some disease processes that have been manageable because of advancements in vascular access. Additionally, children in hospitals frequently require vascular access for various medical reasons. This need can range from temporary or short-term to long-term or even permanent access.
Another important factor expected to positively impact the growth of the market is the growing number of initiatives launched by various governments to raise awareness of the effective treatment of these disorders. The market is further encouraged by increased demand for solutions that minimize problem rates due to increased awareness of the costs associated with catheter-related complications in healthcare facilities. Recent clinical studies have demonstrated that inappropriate use and maintenance of vascular access devices may contribute significantly to the difficulties. By offering online or live training programs, manufacturers can set their goods apart from their rivals for the end user and promote brand loyalty.
According to a UN assessment of aging policy, France, like other European nations, is experiencing a steady and large rise in the population of senior people. In 2012, there were 15 million persons in France over the age of 60. In 2060, this number will increase to 24 million. It is anticipated that the market will grow as the number of non-communicable diseases increases with the growing aging populations in these regional nations.
The Germany market dominated the Europe Vascular Access Device Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $607.5 million by 2030. The UK market is exhibiting a CAGR of 6.1% during (2023-2030). Additionally, The France market would experience a CAGR of 7.7% during (2023-2030).
Based on Application, the market is segmented into Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing. Based on End-user, the market is segmented into Hospital, Clinics & Ambulatory Care Centers and Others. Based on Type, the market is segmented into Central Vascular Access Device (Tunneled Catheters, Peripherally Inserted Central Catheters, Non-tunneled Catheters, and Implanted Ports), Peripheral Vascular Access Device (Peripheral Midlines Devices, Peripheral Short Devices and Butterfly/winged Steel Needles) and Accessories. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ICU Medical, Inc., Teleflex, Inc., B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Becton, Dickinson and Company, AngioDynamics, Inc., Edwards Lifesciences Corporation, Nipro Corporation and Romsons.
Intestinal atresia, small bowel syndrome, and different kinds of cancer are some disease processes that have been manageable because of advancements in vascular access. Additionally, children in hospitals frequently require vascular access for various medical reasons. This need can range from temporary or short-term to long-term or even permanent access.
Another important factor expected to positively impact the growth of the market is the growing number of initiatives launched by various governments to raise awareness of the effective treatment of these disorders. The market is further encouraged by increased demand for solutions that minimize problem rates due to increased awareness of the costs associated with catheter-related complications in healthcare facilities. Recent clinical studies have demonstrated that inappropriate use and maintenance of vascular access devices may contribute significantly to the difficulties. By offering online or live training programs, manufacturers can set their goods apart from their rivals for the end user and promote brand loyalty.
According to a UN assessment of aging policy, France, like other European nations, is experiencing a steady and large rise in the population of senior people. In 2012, there were 15 million persons in France over the age of 60. In 2060, this number will increase to 24 million. It is anticipated that the market will grow as the number of non-communicable diseases increases with the growing aging populations in these regional nations.
The Germany market dominated the Europe Vascular Access Device Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $607.5 million by 2030. The UK market is exhibiting a CAGR of 6.1% during (2023-2030). Additionally, The France market would experience a CAGR of 7.7% during (2023-2030).
Based on Application, the market is segmented into Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing. Based on End-user, the market is segmented into Hospital, Clinics & Ambulatory Care Centers and Others. Based on Type, the market is segmented into Central Vascular Access Device (Tunneled Catheters, Peripherally Inserted Central Catheters, Non-tunneled Catheters, and Implanted Ports), Peripheral Vascular Access Device (Peripheral Midlines Devices, Peripheral Short Devices and Butterfly/winged Steel Needles) and Accessories. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ICU Medical, Inc., Teleflex, Inc., B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Becton, Dickinson and Company, AngioDynamics, Inc., Edwards Lifesciences Corporation, Nipro Corporation and Romsons.
Scope of the Study
By Application
- Drug Administration
- Fluid & Nutrition Administration
- Blood Transfusion
- Diagnostics & Testing
By End-user
- Hospital
- Clinics & Ambulatory Care Centers
- Others
By Type
- Central Vascular Access Device
- Tunneled Catheters
- Peripherally Inserted Central Catheters
- Non-tunneled Catheters
- Implanted Ports
- Peripheral Vascular Access Device
- Peripheral Midlines Devices
- Peripheral Short Devices
- Butterfly/winged Steel Needles
- Accessories
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- ICU Medical, Inc.
- Teleflex, Inc.
- B.Braun Melsungen AG
- Medtronic PLC
- Terumo Corporation
- Becton, Dickinson and Company
- AngioDynamics, Inc.
- Edwards Lifesciences Corporation
- Nipro Corporation
- Romsons
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Europe Vascular Access Device Market by Application
Chapter 6. Europe Vascular Access Device Market by End User
Chapter 7. Europe Vascular Access Device Market by Type
Chapter 8. Europe Vascular Access Device Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- ICU Medical, Inc.
- Teleflex, Inc.
- B. Braun Melsungen AG
- Medtronic PLC
- Terumo Corporation
- Becton, Dickinson and Company
- AngioDynamics, Inc.
- Edwards Lifesciences Corporation
- Nipro Corporation
- Romsons
Methodology
LOADING...
